• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.

作者信息

Leiderman E, Zylberman I, Zukin S R, Cooper T B, Javitt D C

机构信息

Department of Psychiatry, Albert Einstein College of Medicine/Bronx Psychiatric Center, Bronx, New York, USA.

出版信息

Biol Psychiatry. 1996 Feb 1;39(3):213-5. doi: 10.1016/0006-3223(95)00585-4.

DOI:10.1016/0006-3223(95)00585-4
PMID:8837983
Abstract
摘要

相似文献

1
Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.高剂量口服甘氨酸对精神分裂症患者血清水平及阴性症状影响的初步研究：一项开放性试验
Biol Psychiatry. 1996 Feb 1;39(3):213-5. doi: 10.1016/0006-3223(95)00585-4.
2
[Changes in positive and negative symptoms, general psychopathology in schizophrenic patients during augmentation of antipsychotics with glycine: a preliminary 10-week open-label study].[精神分裂症患者在抗精神病药物加用甘氨酸增效治疗期间阳性和阴性症状及一般精神病理学的变化：一项为期10周的初步开放标签研究]
Psychiatr Pol. 2011 Nov-Dec;45(6):825-37.
3
[Could we use a serum level of glycine as a prognostic factor of its efficacy in schizophrenic patients?].我们能否将甘氨酸的血清水平作为其对精神分裂症患者疗效的预后因素？
Psychiatr Pol. 2010 May-Jun;44(3):395-404.
4
[Pharmacologic approach to negative symptoms in schizophrenia].[精神分裂症阴性症状的药理学治疗方法]
Encephale. 1995 Jun;21 Spec No 3:35-40.
5
Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.非缺陷综合征中的阴性症状对抗精神病药物治疗有反应，同时血浆高香草酸浓度会发生变化。
J Psychiatry Neurosci. 1996 May;21(3):167-71.
6
The treatment of negative symptoms: pharmacological and methodological issues.阴性症状的治疗：药理学与方法学问题
Br J Psychiatry Suppl. 1996 May(29):17-22.
7
[Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].[抑郁症状和生物胺作为儿童及青少年精神分裂症治疗反应的预测指标]
Z Kinder Jugendpsychiatr Psychother. 1998 Dec;26(4):235-43.
8
Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.盐酸金刚烷胺治疗慢性精神分裂症时症状及血浆高香草酸的变化
Biol Psychiatry. 1997 May 15;41(10):1062-4. doi: 10.1016/S0006-3223(97)00003-6.
9
Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.长效利培酮治疗精神分裂症的安全性和有效性：一项针对从典型及非典型口服抗精神病药物转换而来的稳定患者进行的为期12周的多中心开放标签研究。
J Clin Psychiatry. 2004 Aug;65(8):1084-9.
10
Coadministration of fluvoxamine increases serum concentrations of haloperidol.
J Clin Psychopharmacol. 1994 Oct;14(5):340-3.

引用本文的文献

1
Neuron-Specific Glycine Metabolism Links Transfer RNA Epitranscriptomic Regulation to Complex Behaviors.神经元特异性甘氨酸代谢将转运核糖核酸表观转录组调控与复杂行为联系起来。
Biol Psychiatry Glob Open Sci. 2024 Dec 14;5(2):100432. doi: 10.1016/j.bpsgos.2024.100432. eCollection 2025 Mar.
2
Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways.精神分裂症认知障碍治疗的进展：靶向 NMDA 受体通路。
Int J Mol Sci. 2024 Oct 3;25(19):10668. doi: 10.3390/ijms251910668.
3
Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.
D-氨基酸治疗抵抗性精神分裂症的合理性和转化意义：从神经生物学到临床。
Biomolecules. 2022 Jun 29;12(7):909. doi: 10.3390/biom12070909.
4
Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia.精神病的替代疗法：精神分裂症治疗中的潜在植物化学物质和药物靶点
Front Pharmacol. 2022 May 17;13:895668. doi: 10.3389/fphar.2022.895668. eCollection 2022.
5
Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia.直接和间接靶向甘氨酸调节位点以调节NMDA受体功能，满足精神分裂症患者未被满足的医疗需求。
Front Psychiatry. 2021 Oct 1;12:742058. doi: 10.3389/fpsyt.2021.742058. eCollection 2021.
6
Electroretinographic Abnormalities and Sex Differences Detected with Mesopic Adaptation in a Mouse Model of Schizophrenia: A and B Wave Analysis.明适应状态下精神分裂症小鼠模型的视网膜电图异常和性别差异：A 波和 B 波分析。
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):16. doi: 10.1167/iovs.61.2.16.
7
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1.甘氨酸转运体1口服生物可利用的强效选择性抑制剂的鉴定
ACS Med Chem Lett. 2010 Jun 25;1(7):350-4. doi: 10.1021/ml1001085. eCollection 2010 Oct 14.
8
NMDA receptor and schizophrenia: a brief history.NMDA 受体与精神分裂症：简要的历史。
Schizophr Bull. 2012 Sep;38(5):920-6. doi: 10.1093/schbul/sbs076.
9
Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.靶向离子型谷氨酸受体治疗精神分裂症的最新进展。
Curr Pharm Biotechnol. 2012 Jun;13(8):1535-42. doi: 10.2174/138920112800784899.
10
Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.产前免疫激活或 MK-801 暴露大鼠前额皮质细胞外谷氨酸受帕利哌酮和利培酮的影响。
Neurosci Lett. 2011 Aug 18;500(3):167-71. doi: 10.1016/j.neulet.2011.06.011. Epub 2011 Jun 15.